Arkolith/Insider Trading/IOBT/Form 4

Andersson Claus A.

DirectorIO Biotech, Inc. (IOBT) · full profile →Form 4 · filed Nov 12, 2021
Net Buying
Open-Market Buys
$1.1M
Open-Market Sells
$0
Net Open-Market Flow
$1.1M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 9, 2021Conversion(C)355K——1.7M
Nov 9, 2021Conversion(C)1.4M——1.4M
Nov 9, 2021Buy(P)75K$14.00$1.1M1.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 9, 2021Conversion(C)28K—$00
Nov 9, 2021Conversion(C)148K—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-21-037657) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML